Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04608019 · ClinicalTrials.gov registry record · NA
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study
A NA study, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT04608019: Completed NA study, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
NCT04608019 is a NA study that has completed, run by University of Washington, the Collaborative Health Studies Coordinating Center. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04608019, a NA study, has completed, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
STOP PEDS is a pilot study of children with CF ages 6-18 across 10 sites in North America. The primary goal is to assess the acceptability and feasibility of a multicenter randomized trial comparing immediate antibiotics versus tailored therapy for pulmonary exacerbation (PEx) treatment in this population.
Primary Outcome
The proportion of participants in the tailored arm who did not take any oral antibiotics in the 28 days following randomization
Interventions
- OTHER Immediate Antibiotics
- OTHER Tailored Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2022-08-18 |
| Phase | NA |
Sponsor
University of Washington, the Collaborative Health Studies Coordinating Center5 total trials
What the finished NCT04608019 record still lists
NCT04608019 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Immediate Antibiotics is the first listed.
NCT04608019 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04608019 about?
NCT04608019 is a clinical study titled "Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Pilot Study". STOP PEDS is a pilot study of children with CF ages 6-18 across 10 sites in North America. The primary goal is to assess the acceptability and feasibility of a multicenter randomized trial comparing immediate antibiotics versus tailored therapy for pulmonary exacerbation (PEx) treatment in this popu...
What is the current status of trial NCT04608019?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2020-11-10. Estimated completion is 2022-08-18.
What interventions are being tested in trial NCT04608019?
The interventions under investigation include: Immediate Antibiotics (OTHER), Tailored Treatment (OTHER).
Who is sponsoring clinical trial NCT04608019?
This trial is sponsored by University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04608019's enrollment target sits among peer trials
121 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI